Karen D. Schultz

The Changing Face of Pleural Empyemas in Children: Epidemiology and Management

Karen D. Schultz, Leland L. Fan, Jay R. Pinsky et al. · PEDIATRICS · 2004 · 232 citations

Medicine, Infectious Diseases, Pediatrics +17

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

Nicole Mayer-Hamblett, Félix Ratjen, Renee Russell et al. · The Lancet Respiratory Medicine · 2022 · 126 citations · Full text

Pharmacy, Pharmacotherapy, Good Clinical Practice +8

Treatment of cast bronchitis with low‐dose oral azithromycin

Karen D. Schultz, Christopher M. Oermann · Pediatric Pulmonology · 2003 · 55 citations

Medicine, Clinical Sciences, Pediatrics +13

Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study

Patrick A. Flume, Reta Fischer Biner, D.G. Downey et al. · The Lancet Respiratory Medicine · 2021 · 51 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13